====== Alexion Pharmaceuticals ======

{{ :pharmaceutical_companies:4140404_4135176_id-alxn-logo-r.jpeg?200|}}

Alexion became the rare disease division of [[pharmaceutical_companies:AstraZeneca]] after being acquired by the company in 2021.((Kemp, A. (2021, July 21). //Acquisition of Alexion completed.// AstraZeneca. https://archive.ph/c5apv))

===== COVID-19 =====

The company had been running clinical trials on ULTOMIRIS (ravulizumab-cwvz) in hospitalized COVID-19 patients until they were paused in January 2021 due to lack of efficacy.((Goulart, M. (2021, January 13). //Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized
Patients with Severe COVID-19.// Alexion Pharmaceuticals, Inc. https://archive.ph/u2NbV))

===== Payments from Alexion =====

The following is a developing list of individuals and organizations that Alexion has given money to related to the COVID-19 pandemic:

^ Name  ^ Type  ^ Amount  ^ Description ^
| [[:Ronald McDonald House Charities]]  | Grant  | $200,000.00  | Alexion awarded RMHC a Rare Belonging® grant in 2020.((//Corporate Sponsors of RMHC.// Ronald McDonald House Charities. Retrieved January 17, 2022, from https://archive.ph/UEpBP))  |

===== External links =====

  * [[https://wiki.whiteroseintelligence.com/en/Alexion-Pharmaceuticals|White Rose Wiki]]